SUMMARY
Toll-like receptors (TLRs) activate distinct, yet overlapping sets of signaling
molecules, leading to inflammatory responses to pathogens. Toll-IL-1R (TIR) domains,
present in all TLRs and TLR adapters, mediate protein interactions downstream of activated
TLRs. A peptide library derived from TLR2 TIR was screened for inhibition of TLR2
signaling. Cell-permeable peptides derived from the D helix and the segment immediately N
terminal to TLR2 TIR domain potently inhibited TLR2-mediated cytokine production. The D
helix peptide, 2R9, also potently inhibited TLR4, TLR7, and TLR9, but not TLR3 or
TNF-α signaling. Cell imaging, co-immunoprecipitation, and in
vitro studies demonstrated that 2R9 preferentially targets TIRAP. 2R9
diminished systemic cytokine responses elicited in vivo by synthetic TLR2
and TLR7 agonists; it inhibited activation of macrophages infected with influenza strain
A/PR/8/34 (PR8) and significantly improved survival of PR8-infected mice. Thus, 2R9
represents a TLR-targeting agent that blocks protein interactions downstream of activated
TLRs.